Annual CFF
Summary
- Current Value
- As of today, GRDN annual cash from financing is -$23.65M, up +58.69% on
- Historical Performance
- GRDN annual cash from financing is up +35.72% over the past 3 years, and up +43.09% over the past 5 years
- All-Time High Comparison
- GRDN annual cash from financing is currently -12.19% below its historical high of -$21.08M set on
- 3-Year Low Comparison
- GRDN annual cash from financing is +58.69% above its 3-year low of -$57.23M reached on
- Sector Comparison
- GRDN annual cash from financing is higher than 13.76% of companies in Healthcare sector
Cash From Financing Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | -$23.65M | +58.7% | +35.7% | +43.1% | -12.2% | |
| Quarterly Cash From Financing | -$1.92M | -104.3% | +86.2% | – | – | |
| TTM Cash From Financing | -$56.21M | -595.1% | -106.3% | – | – | |
| Price | $30.32 | +50.7% | – | – | – | |
| Annual Cash From Operations | $57.96M | -18.2% | -0.9% | +3.2% | +32.7% | |
| Annual Cash From Investing | -$30.41M | -126.2% | -131.3% | -83.3% | -46.5% | |
| Annual Dividends Paid | $35.75M | -7.0% | +106.0% | +4.2% | +27.7% | |
| Annual Total Debt | $37.33M | -45.3% | -32.2% | -34.6% | -14.6% | |
| Shares Outstanding | 63.29M | 0.0% | +1.9% | – | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$23.65M | at high | |
| 5Y | -$23.65M | at high | |
| All | -$21.08M | -12.2% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$57.23M | +58.7% | |
| 5Y | -$57.23M | +58.7% | |
| All | -$57.23M | +58.7% |
Cash From Financing History
| Year | Value | Change |
|---|---|---|
| -$23.65M | +58.7% | |
| -$57.23M | -27.1% | |
| -$45.03M | -22.4% | |
| -$36.79M | -7.4% |
| Year | Value | Change |
|---|---|---|
| -$34.26M | +17.5% | |
| -$41.55M | -97.1% | |
| -$21.08M | - |
FAQ
What is the current annual cash from financing of GRDN?
As of today, GRDN annual cash from financing is -$23.65M
What is 1-year change in GRDN annual cash from financing?
GRDN annual cash from financing is up +58.69% year-over-year
What is 3-year change in GRDN annual cash from financing?
GRDN annual cash from financing is up +35.72% over the past 3 years
How far is GRDN annual cash from financing from its all-time high?
GRDN annual cash from financing is currently -12.19% below its historical high of -$21.08M set on December 1, 2018
How does GRDN annual cash from financing rank versus sector peers?
GRDN annual cash from financing is higher than 13.76% of companies in Healthcare sector
When is GRDN next annual earnings release?
The next annual earnings release for GRDN is on
Quarterly CFF
Summary
- Current Value
- As of today, GRDN quarterly cash from financing is -$1.92M, up +40.06% on
- Historical Performance
- GRDN quarterly cash from financing is down -104.28% year-over-year, and up +86.22% over the past 3 years
- All-Time High Comparison
- GRDN quarterly cash from financing is currently -104.28% below its historical high of $44.93M set on
- 3-Year Low Comparison
- GRDN quarterly cash from financing is +96.02% above its 3-year low of -$48.27M reached on
- Sector Comparison
- GRDN quarterly cash from financing is higher than 19.53% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | -$1.92M | +40.1% | -104.3% | +86.2% | – | |
| Annual Cash From Financing | -$23.65M | – | +58.7% | +35.7% | +43.1% | |
| TTM Cash From Financing | -$56.21M | -500.8% | -595.1% | -106.3% | – | |
| Price | $30.32 | +28.0% | +50.7% | – | – | |
| Quarterly Cash From Operations | $28.17M | +41.3% | +1401.7% | +60.5% | – | |
| Quarterly Cash From Investing | -$8.58M | +28.0% | -21.1% | -136.1% | – | |
| Quarterly Dividends Paid | $0.00 | 0.0% | -100.0% | -100.0% | – | |
| Quarterly Total Debt | $34.08M | +1.1% | -54.5% | -40.5% | +100.0% | |
| Shares Outstanding | 63.29M | – | 0.0% | +1.9% | – |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$1.92M | at high | |
| 3Y | $44.93M | -104.3% | |
| 5Y | $44.93M | -104.3% | |
| All | $44.93M | -104.3% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$48.27M | N/A | +96.0% |
| 3Y | -$48.27M | +96.0% | |
| 5Y | -$48.27M | +96.0% | |
| All | -$48.27M | +96.0% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of GRDN?
As of today, GRDN quarterly cash from financing is -$1.92M
What is GRDN quarterly cash from financing most recent change?
GRDN quarterly cash from financing was up +40.06% on September 30, 2025
What is 1-year change in GRDN quarterly cash from financing?
GRDN quarterly cash from financing is down -104.28% year-over-year
How far is GRDN quarterly cash from financing from its all-time high?
GRDN quarterly cash from financing is currently -104.28% below its historical high of $44.93M set on September 30, 2024
How does GRDN quarterly cash from financing rank versus sector peers?
GRDN quarterly cash from financing is higher than 19.53% of companies in Healthcare sector
When is GRDN next earnings release?
The next earnings release for GRDN is on
TTM CFF
Summary
- Current Value
- As of today, GRDN TTM cash from financing is -$56.21M, down -500.81% on
- Historical Performance
- GRDN TTM cash from financing is down -595.08% year-over-year, and down -106.33% over the past 3 years
- All-Time High Comparison
- GRDN TTM cash from financing is currently -595.08% below its historical high of $11.35M set on
- 3-Year Low Comparison
- GRDN TTM cash from financing is +1.79% above its 3-year low of -$57.23M reached on
- Sector Comparison
- GRDN TTM cash from financing is higher than 13.44% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | -$56.21M | -500.8% | -595.1% | -106.3% | – | |
| Annual Cash From Financing | -$23.65M | – | +58.7% | +35.7% | +43.1% | |
| Quarterly Cash From Financing | -$1.92M | +40.1% | -104.3% | +86.2% | – | |
| Price | $30.32 | +28.0% | +50.7% | – | – | |
| TTM Cash From Operations | $87.99M | +52.6% | +75.4% | +152.5% | – | |
| TTM Cash From Investing | -$32.52M | -4.8% | -30.4% | -298.9% | – | |
| TTM Dividends Paid | $300.00K | -99.6% | -99.7% | -98.0% | – | |
| Quarterly Total Debt | $34.08M | +1.1% | -54.5% | -40.5% | +100.0% | |
| Shares Outstanding | 63.29M | – | 0.0% | +1.9% | – |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$9.36M | -500.8% | |
| 3Y | $11.35M | -595.1% | |
| 5Y | $11.35M | -595.1% | |
| All | $11.35M | -595.1% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$56.21M | at low | |
| 3Y | -$57.23M | +1.8% | |
| 5Y | -$57.23M | +1.8% | |
| All | -$57.23M | +1.8% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of GRDN?
As of today, GRDN TTM cash from financing is -$56.21M
What is GRDN TTM cash from financing most recent change?
GRDN TTM cash from financing was down -500.81% on September 30, 2025
What is 1-year change in GRDN TTM cash from financing?
GRDN TTM cash from financing is down -595.08% year-over-year
How far is GRDN TTM cash from financing from its all-time high?
GRDN TTM cash from financing is currently -595.08% below its historical high of $11.35M set on September 30, 2024
How does GRDN TTM cash from financing rank versus sector peers?
GRDN TTM cash from financing is higher than 13.44% of companies in Healthcare sector
When is GRDN next earnings release?
The next earnings release for GRDN is on
Cash From Financing Formula
Data Sources & References
- GRDN Official Website guardianpharmacy.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802255/000119312525274298/0001193125-25-274298-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802255/000119312525064082/0001193125-25-064082-index.htm
- GRDN Profile on Yahoo Finance finance.yahoo.com/quote/GRDN
- GRDN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/grdn